2026 Summer Intern PhD Student - Chemical Process Development - ANALYTICAL at Bristol-Myers Squibb

New Brunswick, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Entry Level & New GradExperience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Currently enrolled in an accredited university program
Interest in analytical chemistry and chemical process development

Responsibilities

Design and execute experiments to evaluate advanced features of online LC, including heterogeneous sampling and online quenching/derivatization
Collaborate with cross-functional teams to select and monitor representative chemical reactions
Analyze and interpret chromatographic data to provide insight into reaction mechanisms, kinetics, and process optimization
Develop and optimize sample handling protocols for challenging compounds

Skills

Key technologies and capabilities for this role

Analytical ChemistryOnline Liquid Chromatography (LC)Reaction MonitoringOrganic ChemistryChemical Process Development

Questions & Answers

Common questions about this position

What is the hourly compensation for this summer internship?

The starting hourly compensation for this assignment is $43.00/hr. Note that the final individual compensation and any applicable benefits will be determined by your employer of record and may vary based on factors like experience, skills, and location.

Is this internship remote or onsite, and where is it located?

The position is located in New Brunswick, NJ, indicating it is an onsite role.

What skills or background are required for this PhD intern role?

The role requires a PhD student background in analytical chemistry or related field, with a focus on developing innovative analytical workflows for real-time reaction monitoring using Online Liquid Chromatography (LC) for small molecule and antibody-drug conjugate (ADC) applications. Highly-motivated candidates with relevant experience are sought.

What is the company culture like at Bristol Myers Squibb?

BMS offers a challenging, meaningful, and life-changing work environment with opportunities to grow alongside high-achieving teams, emphasizing balance, flexibility, and transformative work in patient care.

What are the program dates and application details for this internship?

The program runs from Monday, June 1st 2026 to Friday, August 7th 2026 (~10 weeks), with applications accepted on a rolling basis and selected candidates notified no later than February 2026. It includes mentorship, orientation, exposure to leadership, and a final presentation.

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free